Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03573544
Title This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OBI Pharma, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Scripps Clinic Torrey Pines La Jolla California 92037 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
West Cancer Center and Research Institute Germantown Tennessee 38138 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
China Medical University Hospital Taichung 40447 Taiwan Details
National Cheng Kung University Hospital Tainan 704 Taiwan Details
Taipei Veterans General Hospital Taipei 11217 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field